Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-09

Clinical Trial Update: CorWave LVAS FIH Study [NA]

View source ↗

Summary

CorWave's left ventricular assist system (LVAS) first-in-human study is currently recruiting for advanced heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CorWave LVAS

Snippet

Sponsor: CorWave | Conditions: Advanced Heart Failure | NA | Status: RECRUITING